Ilex paraguariensis leaf
- Generic Name
- Ilex paraguariensis leaf
- Drug Type
- Biotech
- Unique Ingredient Identifier
- 1Q953B4O4F
- Background
Ilex paraguariensis leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
A Study on the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers
Phase 3
Terminated
- Conditions
- Respiratory Syncytial Virus Infections
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-07-28
- Last Posted Date
- 2025-04-20
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 384
- Registration Number
- NCT04980391
- Locations
- 🇪🇸
GSK Investigational Site, TorrejOn Ardoz Madrid, Spain
A Phase III Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers
Phase 3
Terminated
- Conditions
- Respiratory Syncytial Virus Infections
- Interventions
- Drug: Placebo
- First Posted Date
- 2020-10-27
- Last Posted Date
- 2025-02-20
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 10578
- Registration Number
- NCT04605159
- Locations
- 🇬🇧
GSK Investigational Site, Edinburgh, United Kingdom
Galantamine and CBT4CBT Pilot to Prevent Relapse.
Early Phase 1
Completed
- Conditions
- Methadone or Buprenorphine Detoxoxification
- Interventions
- First Posted Date
- 2018-06-06
- Last Posted Date
- 2022-08-19
- Lead Sponsor
- Yale University
- Target Recruit Count
- 6
- Registration Number
- NCT03547622
- Locations
- 🇺🇸
APT Foundation, New Haven, Connecticut, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath